Report Detail

Other Global Artificial Intelligence Pathology Diagnosis Market Growth (Status and Outlook) 2022-2028

  • RnM4484115
  • |
  • 18 August, 2022
  • |
  • Global
  • |
  • 104 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

The global market for Artificial Intelligence Pathology Diagnosis is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Artificial Intelligence Pathology Diagnosis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Artificial Intelligence Pathology Diagnosis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Artificial Intelligence Pathology Diagnosis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Artificial Intelligence Pathology Diagnosis market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Artificial Intelligence Pathology Diagnosis players cover Aiforia, AIRA Matrix, Deep Bio, DoMore Diagnostics and Indica Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Artificial Intelligence Pathology Diagnosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Artificial Intelligence Pathology Diagnosis market, with both quantitative and qualitative data, to help readers understand how the Artificial Intelligence Pathology Diagnosis market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Artificial Intelligence Pathology Diagnosis market and forecasts the market size by Type (Histopathology, Cytopathology and Immunohistochemical Pathology), by Application (Hospital, Diagnostic Laboratory and Training and Education,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology

Segmentation by application
Hospital
Diagnostic Laboratory
Training and Education

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Aiforia
AIRA Matrix
Deep Bio
DoMore Diagnostics
Indica Labs
Mindpeak
Paige AI
Path AI
Tempus
Verily
Aignostics GmbH
Gestalt Diagnostics
Primma

Chapter Introduction
Chapter 1: Scope of Artificial Intelligence Pathology Diagnosis, Research Methodology, etc.
Chapter 2: Executive Summary, global Artificial Intelligence Pathology Diagnosis market size and CAGR, Artificial Intelligence Pathology Diagnosis market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Artificial Intelligence Pathology Diagnosis revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Artificial Intelligence Pathology Diagnosis revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Artificial Intelligence Pathology Diagnosis market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Aiforia, AIRA Matrix, Deep Bio, DoMore Diagnostics, Indica Labs, Mindpeak, Paige AI, Path AI and Tempus, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Artificial Intelligence Pathology Diagnosis Market Size 2017-2028
    • 2.1.2 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Artificial Intelligence Pathology Diagnosis Segment by Type
    • 2.2.1 Histopathology
    • 2.2.2 Cytopathology
    • 2.2.3 Immunohistochemical Pathology
    • 2.2.4 Molecular Pathology
  • 2.3 Artificial Intelligence Pathology Diagnosis Market Size by Type
    • 2.3.1 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Artificial Intelligence Pathology Diagnosis Market Size Market Share by Type (2017-2022)
  • 2.4 Artificial Intelligence Pathology Diagnosis Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Diagnostic Laboratory
    • 2.4.3 Training and Education
  • 2.5 Artificial Intelligence Pathology Diagnosis Market Size by Application
    • 2.5.1 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Artificial Intelligence Pathology Diagnosis Market Size Market Share by Application (2017-2022)

3 Artificial Intelligence Pathology Diagnosis Market Size by Player

  • 3.1 Artificial Intelligence Pathology Diagnosis Market Size Market Share by Players
    • 3.1.1 Global Artificial Intelligence Pathology Diagnosis Revenue by Players (2020-2022)
    • 3.1.2 Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Players (2020-2022)
  • 3.2 Global Artificial Intelligence Pathology Diagnosis Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Artificial Intelligence Pathology Diagnosis by Regions

  • 4.1 Artificial Intelligence Pathology Diagnosis Market Size by Regions (2017-2022)
  • 4.2 Americas Artificial Intelligence Pathology Diagnosis Market Size Growth (2017-2022)
  • 4.3 APAC Artificial Intelligence Pathology Diagnosis Market Size Growth (2017-2022)
  • 4.4 Europe Artificial Intelligence Pathology Diagnosis Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Artificial Intelligence Pathology Diagnosis Market Size by Country (2017-2022)
  • 5.2 Americas Artificial Intelligence Pathology Diagnosis Market Size by Type (2017-2022)
  • 5.3 Americas Artificial Intelligence Pathology Diagnosis Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Artificial Intelligence Pathology Diagnosis Market Size by Region (2017-2022)
  • 6.2 APAC Artificial Intelligence Pathology Diagnosis Market Size by Type (2017-2022)
  • 6.3 APAC Artificial Intelligence Pathology Diagnosis Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Artificial Intelligence Pathology Diagnosis by Country (2017-2022)
  • 7.2 Europe Artificial Intelligence Pathology Diagnosis Market Size by Type (2017-2022)
  • 7.3 Europe Artificial Intelligence Pathology Diagnosis Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Artificial Intelligence Pathology Diagnosis by Region (2017-2022)
  • 8.2 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Artificial Intelligence Pathology Diagnosis Market Forecast

  • 10.1 Global Artificial Intelligence Pathology Diagnosis Forecast by Regions (2023-2028)
    • 10.1.1 Global Artificial Intelligence Pathology Diagnosis Forecast by Regions (2023-2028)
    • 10.1.2 Americas Artificial Intelligence Pathology Diagnosis Forecast
    • 10.1.3 APAC Artificial Intelligence Pathology Diagnosis Forecast
    • 10.1.4 Europe Artificial Intelligence Pathology Diagnosis Forecast
    • 10.1.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Forecast
  • 10.2 Americas Artificial Intelligence Pathology Diagnosis Forecast by Country (2023-2028)
    • 10.2.1 United States Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.2.2 Canada Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.2.3 Mexico Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.2.4 Brazil Artificial Intelligence Pathology Diagnosis Market Forecast
  • 10.3 APAC Artificial Intelligence Pathology Diagnosis Forecast by Region (2023-2028)
    • 10.3.1 China Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.3.2 Japan Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.3.3 Korea Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.3.4 Southeast Asia Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.3.5 India Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.3.6 Australia Artificial Intelligence Pathology Diagnosis Market Forecast
  • 10.4 Europe Artificial Intelligence Pathology Diagnosis Forecast by Country (2023-2028)
    • 10.4.1 Germany Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.4.2 France Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.4.3 UK Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.4.4 Italy Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.4.5 Russia Artificial Intelligence Pathology Diagnosis Market Forecast
  • 10.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Forecast by Region (2023-2028)
    • 10.5.1 Egypt Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.5.2 South Africa Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.5.3 Israel Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.5.4 Turkey Artificial Intelligence Pathology Diagnosis Market Forecast
    • 10.5.5 GCC Countries Artificial Intelligence Pathology Diagnosis Market Forecast
  • 10.6 Global Artificial Intelligence Pathology Diagnosis Forecast by Type (2023-2028)
  • 10.7 Global Artificial Intelligence Pathology Diagnosis Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Aiforia
    • 11.1.1 Aiforia Company Information
    • 11.1.2 Aiforia Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.1.3 Aiforia Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Aiforia Main Business Overview
    • 11.1.5 Aiforia Latest Developments
  • 11.2 AIRA Matrix
    • 11.2.1 AIRA Matrix Company Information
    • 11.2.2 AIRA Matrix Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.2.3 AIRA Matrix Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 AIRA Matrix Main Business Overview
    • 11.2.5 AIRA Matrix Latest Developments
  • 11.3 Deep Bio
    • 11.3.1 Deep Bio Company Information
    • 11.3.2 Deep Bio Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.3.3 Deep Bio Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Deep Bio Main Business Overview
    • 11.3.5 Deep Bio Latest Developments
  • 11.4 DoMore Diagnostics
    • 11.4.1 DoMore Diagnostics Company Information
    • 11.4.2 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.4.3 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 DoMore Diagnostics Main Business Overview
    • 11.4.5 DoMore Diagnostics Latest Developments
  • 11.5 Indica Labs
    • 11.5.1 Indica Labs Company Information
    • 11.5.2 Indica Labs Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.5.3 Indica Labs Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Indica Labs Main Business Overview
    • 11.5.5 Indica Labs Latest Developments
  • 11.6 Mindpeak
    • 11.6.1 Mindpeak Company Information
    • 11.6.2 Mindpeak Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.6.3 Mindpeak Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Mindpeak Main Business Overview
    • 11.6.5 Mindpeak Latest Developments
  • 11.7 Paige AI
    • 11.7.1 Paige AI Company Information
    • 11.7.2 Paige AI Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.7.3 Paige AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Paige AI Main Business Overview
    • 11.7.5 Paige AI Latest Developments
  • 11.8 Path AI
    • 11.8.1 Path AI Company Information
    • 11.8.2 Path AI Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.8.3 Path AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Path AI Main Business Overview
    • 11.8.5 Path AI Latest Developments
  • 11.9 Tempus
    • 11.9.1 Tempus Company Information
    • 11.9.2 Tempus Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.9.3 Tempus Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Tempus Main Business Overview
    • 11.9.5 Tempus Latest Developments
  • 11.10 Verily
    • 11.10.1 Verily Company Information
    • 11.10.2 Verily Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.10.3 Verily Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Verily Main Business Overview
    • 11.10.5 Verily Latest Developments
  • 11.11 Aignostics GmbH
    • 11.11.1 Aignostics GmbH Company Information
    • 11.11.2 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.11.3 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Aignostics GmbH Main Business Overview
    • 11.11.5 Aignostics GmbH Latest Developments
  • 11.12 Gestalt Diagnostics
    • 11.12.1 Gestalt Diagnostics Company Information
    • 11.12.2 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.12.3 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Gestalt Diagnostics Main Business Overview
    • 11.12.5 Gestalt Diagnostics Latest Developments
  • 11.13 Primma
    • 11.13.1 Primma Company Information
    • 11.13.2 Primma Artificial Intelligence Pathology Diagnosis Product Offered
    • 11.13.3 Primma Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Primma Main Business Overview
    • 11.13.5 Primma Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Artificial Intelligence Pathology Diagnosis. Industry analysis & Market Report on Artificial Intelligence Pathology Diagnosis is a syndicated market report, published as Global Artificial Intelligence Pathology Diagnosis Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Artificial Intelligence Pathology Diagnosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,821.86
5,643.72
3,389.16
6,778.32
560,858.40
1,121,716.80
308,647.80
617,295.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report